United States · 
What does Alta Partners invest in?
Alta Partners invests most often at Series B and Series C (51% of the rounds on record), in sectors such as Connected Health, Healthier Living and Healthtech.
Alta Partners highlights
- 01
150 rounds on record
- 02
Mostly Series B and Series C: 51% of its rounds
- 03
Sole investor in 2 rounds, median $23M
- 04
26 exits from the portfolio
What they do
Alta Partners is a leading healthcare and life sciences venture capital firmFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Connected HealthHealthier LivingHealthtech
- Based in
- Jackson, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first150 appearances
- 2019
2 rounds
- Nov
- May
- 2017
1 round
- Sept
- 2014
7 rounds
- Sept
- Aug
- Aug
- Jul
- Mar
- Mar
- Feb
- 2013
9 rounds
- Dec
- Dec
- Oct
- Jul
- May
- May
- Apr
- Mar
- Jan
- 2012
7 rounds
- Dec
- Dec
- Dec
- Nov
- Nov
- Oct
- May
- 2011
4 rounds
- Jul
- Mar
- Feb
- Jan
- 2010
14 rounds
- Nov
- Oct
- Oct
- Jul
- Jul
- Jul
- Jul
- Jun
- Jun
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration7 named
BSBob S. MoreManager of General PartneriFiling they signed
DSDaniel Spencer JanneyManaging Member of the General PartneriFiling they signed
LSLarry S. RandallChief Financial OfficeriFiling they signed
LELaurence Eliot RandallCFOiForm ADV
PSPete S. HudsonManager of General PartneriFiling they signed
PAPeter Alan HudsonPartneriForm ADV
RJRobert Joseph MorePartneriForm ADV
We also hold 14 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$665Mgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- ALTA Partners Management Company, L.P.
- SEC number
- CRD 288423
What they claim to have backed
From their own portfolio page (on their website)
9 of 19 we have independently watched raise
CurasenDembiopharmaDispatchhealthHarborhealthLassentherapeuticsPatientslikemeQihanbioTranscarentVariantbioAlta Partners NextGenEgenesisbioFreemarkethealthKymatheraMarathonProgentosScitheraTyraUmpartnersVir
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed26 in all
ZS PharmaBought by AstraZeneca$2.7BNov 2015
Lumena PharmaceuticalsBought by Shire$260MMay 2014
Aerie PharmaceuticalsListedUndisclosedOct 2013
CeregeneBought by Sangamo BioSciencesUndisclosedAug 2013
Tacit KnowledgeBought by NewgisticsUndisclosedAug 2013
Portola PharmaceuticalsListed$100MMay 2013
SARcode BioscienceBought by Shire$160MMar 2013
nCircle Network SecurityBought by TripwireUndisclosedMar 2013
Aegis LightwaveBought by Photop TechnologiesUndisclosedJan 2013
XeleratedBought by Marvell TechnologyUndisclosedApr 2012
Excaliard PharmaceuticalsBought by Excaliard PharmaceuticalsUndisclosedNov 2011
PlexxikonBought by Daiichi Sankyo$935MFeb 2011
Calistoga PharmaceuticalsBought by Gilead Sciences$375MFeb 2011
Taligen TherapeuticsBought by Alexion Pharmaceuticals$111MJan 2011
Avid RadiopharmaceuticalsBought by Eli Lilly$800MNov 2010
Foldrx PharmaceuticalsBought by PfizerUndisclosedSept 2010
Coapt SystemsBought by MicroAireUndisclosedAug 2010
Intradigm CorporationBought by Silence TherapeuticsUndisclosedDec 2009
BiovitrumBought by Swedish Orphan Biovitrum$493MNov 2009
The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.